Real-world data (RWD) and real-world evidence (RWE) are playing an exponential role in making right decisions in health care industry. This data holds the potential to allow us to design better clinical studies in the health care setting to answer questions previously thought infeasible. The emerging use of these types of data plays a vital role which supports regulatory decision making, including approval of new indications for already approved drugs, generating plethora of opportunities to both the pharmaceutical industry as well as end users.

ProHelix Clinical offers following comprehensive services spanning from concept to execution for Real-World Evidence (RWE) Studies.

• Provide innovative and easy to use software-enabled Services in most of the therapeutic areas.
• Provide real-world data support your specific product position when it comes to a commercial decision.
• Our technical expert collaborates with your subject matter experts to deliver a unique, intelligent RWE strategy for increased clinical research efficiency and targeted plans.
• Provide dedicated team in addition to our clinical operations team, experienced in handling Real-world Studies.
• More than 12 real-world evidence (RWE) studies have been completed in over 10,000 subject populations in multiple therapeutic areas.
• 80% of Real-World Evidence (RWE) Studies executed by us have been completed and published in local and international journals.